Hematopoietic Stem Cell TransplantationCord Blood Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseHematopoietic Stem CellsTransplantation ConditioningTransplantation, AutologousFetal BloodHematologic NeoplasmsStem Cell TransplantationTransplantation ChimeraBone MarrowHistocompatibility TestingTissue DonorsGraft SurvivalBone Marrow CellsHistocompatibilityWhole-Body IrradiationLiver TransplantationLeukemiaPeripheral Blood Stem Cell TransplantationTreatment OutcomeStem CellsMyeloablative AgonistsHematopoiesisHLA AntigensAnemia, AplasticChimerismRecurrenceGraft vs Leukemia EffectBusulfanKidney TransplantationHematologic DiseasesRetrospective StudiesImmunosuppressive AgentsLeukemia, Myeloid, AcuteAllograftsAntigens, CD34Time FactorsGraft RejectionUnrelated DonorsMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisTransplantation, IsogeneicCytomegalovirus InfectionsVidarabineColony-Forming Units AssayCombined Modality TherapyTransplantation ImmunologyDisease-Free SurvivalSurvival RateRemission InductionHematopoietic Stem Cell MobilizationCyclophosphamideHeart TransplantationBlood BanksAntilymphocyte SerumAcute DiseaseHepatic Veno-Occlusive DiseaseCell DifferentiationMice, Inbred C57BLTransplantsCell TransplantationBone and BonesLung TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSevere Combined ImmunodeficiencyFollow-Up StudiesOrgan TransplantationMesenchymal Stem Cell TransplantationMultiple MyelomaBone Marrow PurgingImmunosuppressionGraft vs Tumor EffectLymphocyte TransfusionFlow CytometryLymphocyte DepletionMelphalanT-LymphocytesCell LineageInfectionLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorLeukemia, MyeloidSiblingsTransplantationImmunophenotypingBone Marrow DiseasesRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedImmunogenetic PhenomenaBlood DonorsLeukocyte CountCytomegalovirusCyclosporineCell SeparationInfant, Newborn